betaxolol has been researched along with Obesity in 1 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The antihypertensive and metabolic effects of betaxolol (20 mg/day) were monitored in 40 patients (17 male), aged 54 +/- 2 yr (mean +/- SEM), with moderate essential hypertension." | 5.07 | Betaxolol in obese hypertensive patients. Long-term effects on blood pressure and serum lipids. ( van Brummelen, P; van Os, JS; Woittiez, AJ, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Os, JS | 1 |
| van Brummelen, P | 1 |
| Woittiez, AJ | 1 |
1 trial available for betaxolol and Obesity
| Article | Year |
|---|---|
Betaxolol in obese hypertensive patients. Long-term effects on blood pressure and serum lipids.
Topics: Betaxolol; Blood Pressure; Cholesterol; Drug Evaluation; Female; Humans; Hypertension; Male; Middle | 1992 |